<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 191 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page190.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=191">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 191 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 191</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=191"><img src="../thumb/191.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Respiratory System - 10.2.1                                                    2020-04 / 157
       acts., CNS/psych.effs., headache, tremor, dizzin., dysgeus., palpi-  Drug interactions: Incr.S/E with other sympathomimets., poss.  Dosage: 2 ml inhaled 4xdly as a mist in O2 enriched air through posit.
       tat., tachycard., periph.oed., bronchosp., throat irrit., naus., musc.  hypokalaem.eff. potent. with concom.methylxanth.derivats./ster-  press.ventilat.over 3 mins.
       cramps, myalg., hypokalaem., hyperglycaem., prolong QT, incr.BP,   oids/non-K -spar.diurets., beta-adrenerg.blocks.poss.weak. /an-  Contraindications: ß-block.agents, hyperthyroid., MAOI, pregn.& lactat.
                                          +
       cough, card. dysrhythm./arrest.  tagonis. eff.             Side effects: Tachycard., palpitat., periph. vasodilat., diff.micturit.,
       Warnings & special precautions: Detect.in milk of lactat.rats,   urin.retent., nervousn., headaches, skelet.musc.trem., dizzin., fatig.,
       high.death rate from asthma report.in pts.using long-last.B2-agon.,   OXIS, AstraZeneca  restlessn., insomn., sweat., tens., confus., mouth & throat irrit., N&V,
       only use as addit.ther.where asthma not adeq.control. by other asth-  Formoterol fumarate.  loss of appetite, hypersalivat., hypokalaem., alt.metabol., hypergly-
       ma-controll.meds (ie low-to med-dos.inhal. corticoster.) or where   Indications: Add on ther.to maint.treatm.with inhal.corticoster.for   caem., dyspn., musc. cramps, hypersens.reacts., hyperactiv.in childr.
       dis.sever.warrants two maint. ther.incl.Foradil, monit.adeq. of anti-  prophylax.& treatm.revers. airway obstruct.in asthma, chron.bron-  Special precautions: If usual relief dimin./durat. of act.reduc.seek
       inflamm. ther.& contin. aft.Foradil introd.even if improv. sympt., high.  chit.& emphysema & prevent.of bronchosp.in exerc. induc.asthma,   medic.advice, halogen.anaesth., incr.hypokalaem.risk tog.with other
       incid.of ser.asthma exacerbat. report.esp.in pts.5-12 yrs., do not init./  when adeq.treatm.with corticoster. not suffic.  concom.beta-2-agonists and corticoster./diuret.or xanthin. theref.
                                                                      +
       incr. dos. dur. an asthma exacerbat., if sympts persist/ requirem. incr.  (S4) TURBUHALER. 32/10.2.1/0168.  monit.K conc., paradox.bronchosp.potent., ischaem.heart dis., ang.,
       treatm.to be reassess.by physic., not for relief of ac. asthma sympts.,   840246-005: 9 µg/inhal., 60 inhalat., R432,39  tachycard., arrhythm., hypertens., larg.dos.of other sympathomimet.,
       pts.to seek med. treatm. immed.should asthma sudd.deter., partic.   Dosage: Do not exceed max.dos. Adults: Ac. sympt. relief: 9 µg.   avoid excess.dos., poss.card.effs.with high dos. furth.aggravat.if
       emphas. on dos.limits in ischaem.heart dis./card. dysrrhythm. esp.3   rd  Admin.low.effect.dos.as reqd. in pts.who do not contin.need reg.  admin.concom.with other meds. that cause hypokalaem.& card.
                                     maint.treatm. Pts.on maint.treatm.may be giv.addit.dos. Max. total
       degree /AV block/sev.card. decompensat./ idiopath. subvalvul.aort.  effs.or in presence of hypox.& acidos., hyperthyroid., MI, QT-interv.
       stenos./ sev. hypertens./ aneurysm./phaeochromocytom., hypertroph.   dos.not to exceed.54 µg/24 hrs.(6 inhalat.of the 9 µg inhal.)  prolongat.suscept., diab.mellit. Resp.sol.also: High dos.corticoster.,
       obstruct. cardiomyopathy/thyrotoxicos. & known/ suspect.QTc interv.  Maint.dos: 9 µg (1-2 inhalat.) morn.& even. Max. dly.dos: 36 µg. No   syrup cont.sweetn.
       prolongat., addit.bld. gluc. monit. recomm.in diab., sev.asthma where   more than 3 actuat.on sngl. occas.of 9 µg dos.  Drug interactions: Incr.arrhythm.risk with card. glycos./quinidine or
       hypokalaem. may be potent.by hypox.& concom. treatm., monit.ser.K   Exerc.induc.bronchoconstrict.prev: 9 µg bef. exer.  TCA’s, eff.potent.by xathine derivat./steroids & diuret.
                                     Contraindications: Inhal.lactose hypersens., pregn., lactat.
       lev.in case of ser. hypokalaem., discont.immed.in paradox. bronchosp.,   VENTIMAX CFC FREE, Biotech [P/S]
       safety in pregn.& lactat.not est., lact. intol., concom.other long-act.  Side effects: High dos.relat.prolong.QTc interv., palpitat., headache,   Salbutamol sulph.
       beta 2-agon., concom. ß-adrenerg. block.incl. eye drops, add-on ther.  trem., tachycard., musc. cramps, psych.disords., card.arrhythm., naus.,   Indications: Bronchosp, asthma, COPD.
       to inhal. corticoster.in asthma pts.not adeq.contr./dis. sev. requir. both   bronchosp., exanthema, urticar., prurit., hypo/ hyperkalaem., ang.  (S2) MET.DOS.INHAL, 36/10.2.1/0393
       inhal.corticoster.& long-act.beta-block., reg.monit.with dos.reduct.  pect., hyperglycaem., taste disturbs., dizzin., BP variats.  720723-001: 100 µg/met.dos, 200 inhal., R30,05
                                     Special precautions: Optim.anti-inflammat. ther. with corticoster.
       Drug interactions: Poss QT interv.prolongat./ incr. ventr.arrthythm.  Dosage: 1-2 inhal. repeat.4 hrly.if reqd. May be used to relieve
       risk with quinidine/ disopyramide/ procainamide/phenothiazin./ an-  bef.start.maint.treatm., maint.ther. no substitut.for inhal./oral corticos-  ac.dyspn.or prophylact.bef.exert. prevent.exerc.-induc.asthma. Incr.
       tihist./ macrolid., MAOI’s/TCA’s or any meds. known to prolong QTc-  ter., do not stop/ reduc.corticoster.ther.without medic.advice, re-eval.   dos.& freq.only on medic.advice as adverse effs.with excess.dos.
       interv., addit. sympathomimet. agents may potent.adverse eff., xan-  if use incr.or other short act. bronchodilat. to contr.sympts.reqd., thyro-  Contraindications: Thyrotoxicos., concom.beta-blocks., premat.
                                                            rd
       thine derivat./corticoster./diurets.may potent. poss. hypokalaem. eff.,   toxicos., sev.CV disords. incl. ac.or chron.ischaem.dis./3  degree AV   labour managem., threaten.abort., safety dur.pregn. & lactat.not.
                                     block/ subvalvul.aort.stenos./sev. hypertens. /tachyarrhythm. or sev
       elev.dysrhythm.risk dur. anaesthes. with halogenat.hydrocarb., ß-adr-  est., MAOI’s.
       energ. block. may weak./antagon.eff.provok.bronchosp.in asthmat.  HF, dos.relat. potent.of ser. hypokalaem. poss., high dos.incr.ser.S/E   Side effects: Bronchosp., cough., bronch./ oropharyng. irrit.,
                                     incl.card. dysrhythm., card.dysrhythm.risk aggrav.by concom. meds.
       FORATEC, Cipla Medpro         caus.hypokalaem.& card.dysrhythm.in pres. of hypox.& acidos., hy-  ac.worsen.asthma, dermatit., tachycard., chest discomf./pain, dys-
                                                                  rhythm., hypokalaem., musc.cramps/twitch., GI disturbs., dry mouth/
       Formoterol fumarate.          pokalaem.risk poss.augment. by hypox., monit.ser.K lev.esp.if high.  throat, taste chang., hypersens.reacts. incl. angioed./bronchosp.,
                                                          +
       Indications: Bronchoconstrict.in revers.airway obstruct.dis., prophy-  dos.reqd., sev. liv.cirrhos., hypokalaem.incr.disposit.towards arrhythm.   CNS eff., headache, trembl., dizzin., drowsin., fatig., restlessn., fa-
       lax.of bronchosp.induc.by exerc.chall./inhal.allerg.or non-specific.irrit.  with digital.treatm., concom.ß-adrenerg block. incl.eyedrops unless
       (S4) HFA MET.DOS.INHAL, A40/10.2.1/0413  compell.reas, bld.gluc. monit.init.recomm.in diabet.  talit. with excess.use.
                                                                  Special precautions: CV disords.esp.ischaem. heart dis., pts.receiv.
       710307-001: 12 µg, 120 dos., R151,35  Drug interactions: Xanthine derivat./diuret & corticoster. may po-  large dos.of other sympathomimets., halogen.anaesthet., re-eval.
       Dosage: Maint.& prophylax: Adults incl. elderly & childr. over   tent.hypokalaem.eff., concom. sympathomim. may potent.undesir.  ther./ concom.glucocorticoster.in case of worsen. asthma signs, reg.
       6 yrs: 1 puff 2xdly.morn.& even. Ac.attack: 1-2 addit.puffs may be   effs., quinidine/ disopyramide/ procainamide/phenothiazin., antihis-  eval.in sev.asthma, eff. poss.potent.in ac.sev.asthma by concom.
       inhal., max. dly.dos.is 48 µg or 4 puffs. Max.dly.maint. dos: 2 puffs   tam. eg.terfenadine/MAOI’s & TCA’s can prolong QT interv.& incr.risk   xanth. derivats./steroids/diurets.& hypox., in sev.asthma requir. inhal./
       12 hrly. Reasses ther.if sympt.not controll.by 24 µg dly.  of ventr.arrhythm., eff. weak. /inhib.by ß-adrenerg.block., ß2-adrenerg.   oral corticoster.ther.the inhal. provides essent.rescue med.in treat.
       Exerc.induc.bronchosp.prophylax/bef.expos. to unavoid.al-  stimul. act.on CV syst.potent.by MAOI or TCA’s.  ac.exacerbat., seek med.advice if usual relief dimin./durat.act. reduc.
       lerg: 1 puff 15 mins.bef.                                  Drug interactions: Incr.dysrhythm.risk with card. glycosid./qui-
       Contraindications: Thyrotoxicos., 3rd degr.AV-block., idiopath.sub-  SEREFLO, Cipla Medpro (Pty) Ltd  nidine/TCA’s.
                                     See Section 10.2.4
       valvul.aort.stenos., tachycard., hypertroph. obstruct.cardiomyopathy,
       prolong. congenit./ drug induc.QT interv., safety in childr. und. 6 yrs.,   SERETIDE, GlaxoSmithKline SA (Pty) Ltd  VENTOLIN, GSK [N/P/S] & [PWR]
       MAOI & TCA’s, pregn.& lactat.  See Section 10.2.4          Salbutamol sulph.
       Side effects: Trem., headache, agitat.& other CNS effs., conjunctiv.  Indications: Bronchosp.in bronch.asthma, bronchit., emphys.
       irrit., eyelid oed., palpits., tachycard., aggrav.bronchosp., oropharyng.  SEREVENT, GSK [PWR]  (S2) CFC-FREE INHAL., [PWR] 32/10.2.1/0344. 100 µg/inhal.
       irrit., naus., taste pervers., prurit., exanthema, musc. cramps, my-  Salmeterol xinafoate.  817333-002: 300 met.inhal.refill, R42,30
       alg., hypokalaem.             Indications: Adults: Long-term treatm.of revers. airway obstruct.  703371-003: 200 met.inhal.compl., R79,09
       Special precautions: Partic.emphas.on dos. limits in MI/ischaem.  in asthma, chron.bronchit.& emphys. Childr.4 yrs.& old: Reg.treatm.  775320-005: 200 met.inhal.refill, R28,38
       heart dis./sev.card. decompensat. /card.arrhythm.esp.3  degr.AV   of revers. airway obstruct.in asthma includ.prevent.of exerc. in-  Dosage: 1-2 inhal. 4 hrly.if reqd.
                               rd
       block/sev.aort.stenos./sev.hypertens., sev.asthma where hypoka-  duc.bronchosp.  (S2) ACCUHALER, [PWR] 31/10.2.1/0120.
       laem.may be potent.by hypox.& concom. treatm., monit.ser.K lev.in   (S4) ACCUHALER, [PWR] 29/10.2.1/0350.  857289-004: 200 µg/blister, 60, R183,31
       case of serious hypokalaem., discont.immed.in paradox. bronchosp.,   818496-002: 50 µg/blister, 60 dos., R463,26  Indications: Revers.airways obstruct.in asthma, chron.bronchit.&
       sev.hepat.impairm., digital.treat.pts. more suscept.to card.arrhythm.  Dosage: By inhalat.only. For full therapeut. benefit regul.use recomm.  emphys., bronchosp.prophylax.in exerc.induc. asthma.
       aris.from poss. hypokalaem., addit.bld.gluc.control recomm.in diab.   Adults & childr. 4 yrs.& over: 50 µg 2xdly.  Dosage: Admin.by inhal.route only. Do not exceed 4x dly use.
       due hyperglycaem.eff.         (S4) CFC FREE INHALER, [PWR] A40/10.2.1/0064  Concom. glucocorticoster.ther.to be admin.in sev./unstab.asthma.
       Drug interactions: May potent.CV adverse reacts. of drugs assoc   787302-007: 25 µg/actuat., 120 actuat. R463,26  Ac.bronchosp: Adults & childr.5-12 yrs: 200 µg as requir.
       with QT interv.prolongat., addit.sympathomimet.agents may potent.  Dosage: For full therapeut.benefit regul.use recomm.  Prevent.of allergen/exerc.-induc. bronchosp: Adults & chil-
       adverse reacts., act.on CV syst.potent.by MAOI & TCA’s, xanthine de-  Adults & childr. 4 yrs.& over: 2 inhalat. 2xdly.  dr.5-12 yrs: 200 µg bef. challenge.
       rivat./corticoster./diurets.may potent. hypokalaem.eff., ß-adrenerg.  Side effects: Trem., headache, palpitat., musc. cramps, tachycard.,   Chron.therapy: Adults & childr.5-12 yrs: 200 µg 4xdly. Max.dos.
       block.may provoke bronchosp.in asthmat.& inhib.bronchodilat.eff.  cutan.hypersens.reacts., arthralg., card.arrhythm., oropharyng.irrit.,   not to be exceed.
       Warnings: Cont.unchang.with exist.inhal./oral corticoster., if sympts   poss. paradox.bronchosp., hypokalaem.  Contraindications: Concom.beta-blocks., MAOI’s, lact.intol., in-
       persist/requirem.incr. treatm. to be reassess.  Special precautions: Thyrotoxicos., do not initiate in pts.with wors-  halat.presentat.not appropr. for prem.labour, threaten.abort., safety
                                     en./deteriorat.asthma, sudd.& progress.deteriorat.of asthma contr.   dur.pregn. & lactat.not.est.
       FOXAIR , GlaxoSmithKline SA (Pty) Ltd  requir.immed.attent., not a replacem.for oral/ inhal.corticoster., not   (S3) RESPIRATOR SOL, [PWR] D/10.2.1/203.
       See Section 10.2.4            design.for relief of ac. asthma sympts.  Indications: In conjunct.with intermit.+ve.press.in treat.status asth-
       ONBREZ BREEZHALER, Novartis   VENTEZE, (Aspen Pharmacare: Pharma) Pharmacare   mat./other forms of sev. bronchosp.
                                                                  836001-029: 5 mg/ml, 20 ml, R115,16
       Indacaterol                   [PWR] & [N/P/S]              Dosage: Admin. by inhal.route with respirat./ nebulis. Do not inj./
       Indications: Long term.maint.treatm.of chron. obstruct. pulm.dis.  Salbutamol.  swall. Dil.0,5-1,0 ml (2,5-5,0 mg salbutamol) with NaCl to fin.vol.of
       (S3) DRY POWD.INHALAT.CAPS, 44/10.2.1/0544  Indications: Bronch.asthma, chron.bronchit., emphys.  2,0 or 2,5 ml. Inhal.until aeros.generat.ceas.usual.aft. 10 min. May be
       717402-001: 150 µg, Breezhaler & 30, R350,14  (S2) CFC FREE INHALER, A39/10.2.1/0154  repeat.4x dly. Undil: 2 ml sol.in nebulis. inhal.until bronchodil.achiev.
       Dosage: Do not use more often than recomm.dos. Do not swallow   711213-001: 100 µg, 200 doses, R34,48  usual.aft.3-5 mins. May be repeat.4x/day. Max.dos.not to be exceed.
       caps. Adults: Oral inhalat.of contents of 1 cap. using Breezhaler   Dosage: 1-2 inhal.4 hrly if req. May be used to reliev.ac.dyspn.or   (S3) NEBULES, [PWR] Y/10.2.1/416, 417.
       inhal.once dly.               taken prophylactic.bef.exert.to prev.exerc.-induc.asthma.  Indications: Sev.bronchosp.in conjunct.with O2.
       Side effects: Paradox.bronchosp., nasopharyngit., URTI, cough,   (S2) TABS, [N/P/S] M/10.2/14, 15.  791229-009: 2,5 mg, 30x2,5 ml amps, R226,48
       headache, pneumon., pharyngolaryng. pain, rhinorrh., paraesthes.,   775398-004: 2 mg, 100, R52,12  791237-001: 5 mg, 30x2,5 ml amps, R246,67
       musc. spasm, myalg., neck pain, atrial.fibrillat., ang. pect., chest dis-  775398-012: 2 mg, 500, R260,58  Dosage: Admin.undil. in well-ventilat.room with a nebulis.via inhal.
       comf., diab.mellit., CV effs., ECG chang., hypokalaem.  775401-005: 4 mg, 100, R80,15  route only. Dilut. with saline may be requir.if prolong.deliv.time necess.
       Warnings and special precautions: Asthma, pts.und.18 yrs.,   775401-013: 4 mg, 500, R400,75  Adults: 2,5 mg up to 4xdly, may be incr.to 5 mg. Ther.may be re-
       safety in pregn. & lactat.not est., concom.other long-act. beta2-adr-  Dosage: Admin. 3-4xdly.  peat. up to 4x/day.
       energ.agonists/ meds.contain., discont.if paradox.bronchosp. occurs,   Adults: 2-4 mg. Childr. 2-6 yrs: 1-2 mg. over 6 yrs: 2 mg.  Childr: 20 mnths-12 yrs: 2,5 mg up to 4xdly. If necess.up to 5 mg
       not for use in ac.bronchosp.(ie.rescue ther.), re-eval.in case of con-  (S2) SYRUP, [N/P/S] T/10.2/84. 2 mg/5 ml.  may be req.in some childr.over 6 yrs. Max.dos.not to be exceed.
       dit.deteriorat.whilst on treatm., concom.MAOI/TCA’s/meds.known   775452-009: 100 ml, R16,94  (S4) INJ, [N/P/S] H/10.2.2/118. 500 µg/ml.
       to prolong QT-interv., concom.beta-adrenerg.blocks. not advis.(incl.  775452-017: 500 ml, R84,75  Indications: Sev.bronchosp.assoc.with asthma, bronchit., treatm.of
       eye drops), poss.labour inhibit., CV disords.esp.coron.insuffic./card.  Dosage: Admin. 3-4xdly.  stat.asthmat., prem.labour (suppress. uter.contract.)
       dysrhythm./ hypertens., convuls.disords., thyrotoxicos., pts. unusual.  Childr. 2-6 yrs: 2,5-5 ml. Over 6 yrs: 5 ml. Adults: 5-10 ml.  775347-019: 5x1 ml, R305,83
       respons.to beta-2-adrenerg.agonists, discont. ther.in case of signif.CV   (S3) RESPIRATOR SOL, [PWR] U/10.2.1/187.  Dosage: Dos: IM/SC 500 µg 4 hrly.IV 250 µg slow inj.
       effs., card. dysrhythm. risk with concom. meds.caus. hypokalaem./  Indications: Bronchosp.assoc.with asthma, bronchit., obstruct.  Obstet: 100-250 µg IV/IM. Rep.accord.to respon.
       in pres.of hypox.& acidos., do not exceed max.dos., heredit.lact.in-  pulm.dis.  (S4) IV INFUS.SOL, [N/P/S] H/10.2.2/119.
       tol.probl./sev. lact.defic.   835994-007: 5 mg/ml, 20 ml, R41,17  775355-003: 1 mg/ml, 10x5 ml, R3 132,69</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page190.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page186.html">186</a>&nbsp;&nbsp;&nbsp;<a href="page187.html">187</a>&nbsp;&nbsp;&nbsp;<a href="page188.html">188</a>&nbsp;&nbsp;&nbsp;<a href="page189.html">189</a>&nbsp;&nbsp;&nbsp;<a href="page190.html">190</a>&nbsp;&nbsp;&nbsp;<a href="page191.html">191</a>&nbsp;&nbsp;&nbsp;<a href="page192.html">192</a>&nbsp;&nbsp;&nbsp;<a href="page193.html">193</a>&nbsp;&nbsp;&nbsp;<a href="page194.html">194</a>&nbsp;&nbsp;&nbsp;<a href="page195.html">195</a>&nbsp;&nbsp;&nbsp;<a href="page196.html">196</a>
             </td>
             <td width="35%"><a href="page192.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page192.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
